Did you know?

Nov 27, 2023 · TORONTO, ON / ACCESSWIRE / November 27, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ('FSD Pharma' or the 'Company'), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that it obtained a final order on November 24, 2023 from the Ontario Superior Court of ... Nov 30, 2023 · As described in FSD Pharma's press release dated November 21, 2023, the record date of the Plan of Arrangement was set at November 28, 2023 (" Record Date "). On November 29, 2023, being the ... About FSD Pharma. FSD Pharma Inc. is a biotechnology company with three drug candidates in different stages of development. FSD BioSciences, Inc., a wholly owned subsidiary, is focused on pharmaceutical research and development of its lead compound, FSD201, a proprietary ultra-micronized PEA formulation, for the treatment of …Feb 21, 2023 · TORONTO, February 21, 2023--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative ... FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, today announced that its Australian entity, FSD …Nov 17, 2023 · The special meeting of the FSD Pharma Securityholders to vote on the Arrangement is scheduled to be held on November 20, 2023 (the "Meeting").Additionally, the final hearing at the Ontario ... About FSD Pharma FSD is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of …As previously disclosed in the Company's press release dated November 21, 2023, at a special meeting of the FSD Pharma Securityholders, the special resolution to authorize the Arrangement was ...FSD BioSciences, Inc., a wholly owned subsidiary, is focused on pharmaceutical research and development of its lead compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory ...TORONTO, March 22, 2023--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets ...TORONTO, ON / ACCESSWIRE / November 15, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ('FSD Pharma' or the 'Company'), a …FSD Pharma will hold an annual general and special shareholders meeting on June 29, 2023 (the “Meeting”) where Shareholders will be able vote on the Spin-out Transaction.About FSD Pharma FSD Pharma Inc. is a biotechnology company with three drug candidates in different stages of development. FSD BioSciences, Inc., a wholly owned subsidiary of FSD Pharma, is focused on pharmaceutical research and development of its lead compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory …FSD Pharma Wins $2.8 Million Dollar Award Plus Accruing Interest from Dr. Raza Bokhari; Set Aside Motion Brought by Bokhari, Now CEO of Medicus Pharma, ...FSD Pharma Securityholders are cautioned that there is no certainty that the Arrangement or any of the related matters discussed in the Circular will be completed as currently proposed or at all.FSD Pharma returns to treasury 1,524,700 shares as of 31 March through its buyback program. 4. FSD Pharma adopts the RSU program and issues RSUs in Lieu of options held by Directors and Senior ...Apr 1, 2023 · FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio FSD BioSciences, Inc., a wholly-owned subsidiary, is a specialty biotech pharmaceutical R&D company focused on developing over time multiple applications of its lead compound, ultra-micro PEA by ...၂၀၂၃၊ ဇူ ၁၇ ... FSD Pharma Inc. hired Alan M. Pollack of the Feb 14, 2023 · TORONTO, February 14, 2023--FSD Pha At a special meeting of the FSD Pharma Securityholders held earlier today (the "Meeting"), the special resolution to approve the Arrangement was approved by 100% of the holders of Class A Shares (voting separately as a class) and 99.49% of the holders of Class B Shares and FSD Pharma Distribution Warrants (voting together as a class) that …"FSD Pharma Non-Distribution Warrants" means outstanding warrants of FSD Pharma, each of which is exercisable for the purchase of one Class B Share, and which does not include a provision in its applicable warrant certificate that is substantially in the form attached as Schedule "B" hereto or with the same substantive effect. Upon closing of the Arrangement, FSD Pharma Security FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Company”) today announces that it has entered into a license agreement (the “License TORONTO — FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE)

FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD-201, an ultra-micronized palmitoylethanolamide for the treatment of inflammatory diseases.About FSD Pharma. FSD is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory ...FSD Pharma presented their preclinical toxicology results on FSD201 at the 32nd Annual Symposium of the International Cannabinoid Research Society held in Galway, Ireland on June 25-30, 2022, in a ...TORONTO, March 22, 2023--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets ...

May 12, 2023 · TORONTO, May 12, 2023--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets ... FSD Pharma Inc. is a biotechnology company with three drug candidates in different stages of development. FSD BioSciences, Inc. (“FSD BioSciences”), a wholly …Get the latest stock price for FSD Pharma Inc - Ordinary Shares - Class B (Sub Voting) (HUGE:CNX), plus the latest news, recent trades, charting, ...…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. 355 Followers, 13 Following, 338 Posts - . Possible cause: FSD Pharma Inc. August 2, 2023 at 7:30 AM · 8 min read Launch in the Consumer.